ELMIKO aEEG/CFM System

The ELMIKO aEEG/CFM System is an advanced solution designed for long-term monitoring of brain activity, intended primarily for patients in intensive care units (ICUs), neonatal intensive care units (NICUs), and neonatal pathology wards. The system enables simultaneous recording of raw EEG signals and amplitude-integrated EEG (aEEG) trend curves, allowing real-time visualisation of brain activity and rapid identification of neurological changes.

Applications of the ELMIKO aEEG/CFM System

• Neonatal intensive care units (NICUs)
• Neonatal pathology wards
• Neonatology wards
• Intensive care units (ICUs)
• Neurology wards
• Rehabilitation centres and facilities
• Academic and research institutes

ELMIKO aEEG/CFM System diagnostic indications
The aEEG/CFM module is used in the diagnosis and monitoring of:

• Hypoxic-ischaemic encephalopathy – monitoring brain activity in cases of hypoxia and ischemia to optimise treatment strategies
• Seizures – detection and monitoring of seizure activity, enabling rapid intervention and assessment of the effectiveness of anticonvulsant therapy
• Therapeutic hypothermia – tracking the brain’s response to reduced body temperature used in the treatment of neurological injuries and conditions
• Sepsis – assessment of the effect of sepsis on patients’ brain functioning
• Cardiopulmonary failure – continuous monitoring of brain activity in patients with cardiopulmonary dysfunction
• Neuroinfections – tracking the impact of neurological infections, such as meningitis, on the patient’s condition
• Metabolic disorders – observing brain activity in metabolic abnormalities that may influence neurological status
• Hydrocephalus – controlling the impact of increased intracranial pressure and fluid accumulation on brain functioning
• Pharmacotherapy – assessing the brain’s response to pharmacological treatment to optimise drug dosing and therapeutic protocols

aEEG/CFM module functionalities

• Long-term monitoring – the module enables long-term EEG and aEEG recordings with simultaneous monitoring of physiological parameters such as SpO₂ and ECG, allowing for a comprehensive assessment of brain function in the context of the patient’s overall condition
• Customisable alerts – configurable alerts notify users when predefined thresholds for biological parameters (e.g., oxygen saturation, heart rate, or amplitude) are exceeded, enhancing patient safety during prolonged monitoring
• Integrated display of SpO₂ and rSO₂ on a single CFM trend graph – providing a more accurate understanding of the relationship between respiratory conditions and brain functions
• Continuous impedance monitoring – real-time impedance display with color-coded indicators showing electrode contact quality; alarms alert users when impedance exceeds acceptable limits
• Detection of EEG signal fragments in which increased recurrence of regularity suggests seizures in newborns – integrated EEG and CFM analysis helps identify segments of increased rhythmic activity indicative of neonatal seizures, including episodes that could be overlooked in a standard clinical conditions